|
1
|
Allison KH and Sledge GW: Heterogeneity
and cancer. Oncology (Williston Park). 28:772–778. 2014.PubMed/NCBI
|
|
2
|
Hutter C and Zenklusen JC: The cancer
genome atlas: Creating lasting value beyond its data. Cell.
173:283–285. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res. 45:W98–W102.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
GTEx Consortium: Human genomics. The
genotype-tissue expression (GTEx) pilot analysis: Multitissue gene
regulation in humans. Science. 348:648–660. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhao B, Zhang J, Chen X, Xu H and Huang B:
Mir-26b inhibits growth and resistance to paclitaxel chemotherapy
by silencing the CDC6 gene in gastric cancer. Arch Med Sci.
15:498–503. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang W, Zhang Y, Liu M, Wang Y, Yang T, Li
D, Ding F, Bai G and Li Q: TIMP2 is a poor prognostic factor and
predicts metastatic biological behavior in gastric cancer. Sci Rep.
8:96292018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li X, Wang Z, Tong H, Yan Y and Li S:
Effects of COL8A1 on the proliferation of muscle-derived satellite
cells. Cell Biol Int. 42:1132–1140. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Plenz GA, Deng MC, Robenek H and Volker W:
Vascular collagens: Spotlight on the role of type VIII collagen in
atherogenesis. Atherosclerosis. 166:1–11. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ooshima A and Muragaki Y: Collagen
metabolism in atherogenesis. Ann NY Acad Sci. 598:582–584. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Aldave AJ, Bourla N, Yellore VS, Rayner
SA, Khan MA, Salem AK and Sonmez B: Keratoconus is not associated
with mutations in COL8A1 and COL8A2. Cornea. 26:963–965. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Aldave AJ, Rayner SA, Salem AK, Yoo GL,
Kim BT, Saeedian M, Sonmez B and Yellore VS: No pathogenic
mutations identified in the COL8A1 and COL8A2 genes in familial
Fuchs corneal dystrophy. Invest Ophthalmol Vis Sci. 47:3787–3790.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Di Y, Chen D, Yu W and Yan L: Bladder
cancer stage-associated hub genes revealed by WGCNA co-expression
network analysis. Hereditas. 156:72019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shang J, Wang F, Chen P, Wang X, Ding F,
Liu S and Zhao Q: Co-expression network analysis identified COL8A1
is associated with the progression and prognosis in human colon
adenocarcinoma. Dig Dis Sci. 63:1219–1228. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao Y, Jia L, Mao X, Xu H, Wang B and Liu
Y: siRNA-targeted COL8A1 inhibits proliferation, reduces invasion
and enhances sensitivity to D-limonence treatment in
hepatocarcinoma cells. IUBMB Life. 61:74–79. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Subhash VV, Yeo MS, Wang L, Tan SH, Wong
FY, Thuya WL, Tan WL, Peethala PC, Soe MY, Tan DSP, et al:
Anti-tumor efficacy of Selinexor (KPT-330) in gastric cancer is
dependent on nuclear accumulation of p53 tumor suppressor. Sci Rep.
8:122482018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li WQ, Hu N, Burton VH, Yang HH, Su H,
Conway CM, Wang L, Wang C, Ding T, Xu Y, et al: PLCE1 mRNA and
protein expression and survival of patients with esophageal
squamous cell carcinoma and gastric adenocarcinoma. Cancer
Epidemiol Biomarkers Prev. 23:1579–1588. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Brasacchio D, Busuttil RA, Noori T,
Johnstone RW, Boussioutas A and Trapani JA: Down-regulation of a
pro-apoptotic pathway regulated by PCAF/ADA3 in early stage gastric
cancer. Cell Death Dis. 9:4422018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cristescu R, Lee J, Nebozhyn M, Kim KM,
Ting JC, Wong SS, Liu J, Yue YG, Wang J, Yu K, et al: Molecular
analysis of gastric cancer identifies subtypes associated with
distinct clinical outcomes. Nat Med. 21:449–456. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ooi CH, Ivanova T, Wu J, Lee M, Tan IB,
Tao J, Ward L, Koo JH, Gopalakrishnan V, Zhu Y, et al: Oncogenic
pathway combinations predict clinical prognosis in gastric cancer.
PLoS Genet. 5:e10006762009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim HK, Choi IJ, Kim CG, Kim HS, Oshima A,
Yamada Y, Arao T, Nishio K, Michalowski A and Green JE: Three-gene
predictor of clinical outcome for gastric cancer patients treated
with chemotherapy. Pharmacogenomics J. 12:119–127. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nagy Á, Lánczky A, Menyhárt O and Győrffy
B: Validation of miRNA prognostic power in hepatocellular carcinoma
using expression data of independent datasets. Sci Rep. 8:92272018.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhao X, Hao S, Wang M, Xing D and Wang C:
Knockdown of pseudogene DUXAP8 expression in glioma suppresses
tumor cell proliferation. Oncol Lett. 17:3511–3516. 2019.PubMed/NCBI
|
|
23
|
Peng C, Li X, Yu Y and Chen J: LncRNA
GASL1 inhibits tumor growth in gastric carcinoma by inactivating
the Wnt/β catenin signaling pathway. Exp Ther Med. 17:4039–4045.
2019.PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jin H, Zhang Q, Zhang S, Liu H, Man Z and
Wang Y: Effects of claudin-1 downregulation on the physiological
processes of gallbladder cancer SGC996 cells. Oncol Lett.
17:1688–1694. 2019.PubMed/NCBI
|
|
26
|
Liu X, Wu J, Zhang D, Bing Z, Tian J, Ni
M, Zhang X, Meng Z and Liu S: Identification of potential key genes
associated with the pathogenesis and prognosis of gastric cancer
based on integrated bioinformatics analysis. Front Genet.
9:2652018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang Z, Chen G, Wang Q, Lu W and Xu M:
Identification and validation of a prognostic 9-genes expression
signature for gastric cancer. Oncotarget. 8:73826–73836. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen J, Wang X, Hu B, He Y, Qian X and
Wang W: Candidate genes in gastric cancer identified by
constructing a weighted gene co-expression network. Peer J.
6:e46922018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhuo W, Liu Y, Li S, Guo D, Sun Q, Jin J,
Rao X, Li M, Sun M, Jiang M, et al: Long noncoding RNA GMAN,
up-regulated in gastric cancer tissues, is associated with
metastasis in patients and promotes translation of ephrin a1 by
competitively binding GMAN-AS. Gastroenterology. 156:676–691. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jeong MH, Park SY, Lee SH, Seo J, Yoo JY,
Park SH, Kim MJ, Lee S, Jang S, Choi HK, et al: EPB41L5 mediates
TGFβ-induced metastasis of gastric cancer. Clin Cancer Res.
25:3617–3629. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Almhanna K, Strosberg J and Malafa M:
Targeting AKT protein kinase in gastric cancer. Anticancer Res.
31:4387–4392. 2011.PubMed/NCBI
|
|
34
|
Yang M and Huang CZ: Mitogen-activated
protein kinase signaling pathway and invasion and metastasis of
gastric cancer. World J Gastroenterol. 21:11673–11679. 2015.
View Article : Google Scholar : PubMed/NCBI
|
